Steven H. Bloom - 01 May 2025 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role: Chief Business Officer
Signature: /s/ Jonathan Owen, Attorney-in-fact
Issuer symbol: HOWL
Transactions as of: 01 May 2025
Net transactions value: $0
Form type: 4
Filing time: 02 May 2025, 17:38:59 UTC
Previous filing: 18 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bloom Steven H.	Chief Business Officer	C/O WEREWOLF THERAPEUTICS, INC., 200 TALCOTT AVENUE, 2ND FLOOR, WATERTOWN	/s/ Jonathan Owen, Attorney-in-fact	02 May 2025	0001722642

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HOWL	Stock Option (right to buy)	Award	$0	+201,720		$0.000000	201,720	01 May 2025	Common Stock	201,720	$0.8700	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted as an inducement material to Mr. Bloom's entering into employment with Werewolf Therapeutics, Inc. (the "Company") in accordance with Nasdaq Listing Rule 5635(c)(4). The option has a ten-year term and vests as to 25% on April 16, 2026, the first anniversary of the effective date of Mr. Bloom's employment, and the remaining 75% vests in 36 equal monthly installments thereafter, subject to continued service by Mr. Bloom to the Company or any of its subsidiaries through each applicable vesting date.

Content

The option was granted as an inducement material to Mr. Bloom's entering into employment with Werewolf Therapeutics, Inc. (the "Company") in accordance with Nasdaq Listing Rule 5635(c)(4). The option has a ten-year term and vests as to 25% on April 16, 2026, the first anniversary of the effective date of Mr. Bloom's employment, and the remaining 75% vests in 36 equal monthly installments thereafter, subject to continued service by Mr. Bloom to the Company or any of its subsidiaries through each applicable vesting date.